Saori Mishima

14PUBLICATIONS
73CO-AUTHORS
Predictive and prognostic markersPacific Peoples theory of change models for healthCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 20, 2026
Clinical significance of WES-defined ERBB2 amplification in resectable colorectal cancer.

|Oct 29, 2025
Exploring Health Care Needs and HR-QOL Among Women With Cancer: A Principal Component Analysis Before and 6 Months After Treatment Initiation.

Michiyo Mizuno, Ikuko Chiba, Natsumi Oda

|Mar 21, 2025
Circulating Tumor DNA Assessment to Predict Risk of Recurrence After Surgery in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Observational Study.

Shogo Takei, Daisuke Kotani, George Laliotis

|Nov 08, 2024
A Tumor-Naïve ctDNA Assay Detects Minimal Residual Disease in Resected Stage II or III Colorectal Cancer and Predicts Recurrence: Subset Analysis from the GALAXY Study in CIRCULATE-Japan.

Yoshiaki Nakamura, Kristiyana Kaneva, Christine Lo

|Mar 02, 2024
Whole-transcriptome sequencing in advanced gastric or gastroesophageal cancer: A deep dive into its clinical potential.

Tadayoshi Hashimoto, Yoshiaki Nakamura, Saori Mishima

|Jan 24, 2024
Japanese Society of Medical Oncology clinical guidelines: Molecular testing for colorectal cancer treatment, 5th edition.

Hideaki Bando, Kyoko Yamaguchi, Seiichiro Mitani

Pageof 3

Frequent Collaborators

7 joint publications

Takayuki Yoshino

7 joint publications

Hideaki Bando

6 joint publications

Yoshiaki Nakamura

5 joint publications

Daisuke Kotani